Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Kali-Extracts Releases Preclinical Research Study Results On Therapy For Respiratory Disease Driving $11 Billion Treatment Mrkt
Print
Dallas, TX -- December 19, 2018 -- InvestorsHub NewsWire -- Kali, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the new Kali Cannabis Therapies subsidiary to develop cannabis biotechnology treatment alternatives to chemical pharmaceuticals. On November 15th, 2018, KALY acquired NCM Biotech to include a patented cannabis extraction process and associated intellectual properties consisting of years of preclinical research studies surrounding a multitude of applications of cannabis extracts derived from the patented cannabis extraction process. The acquired cannabis biotechnology intellectual properties will be contained within the new Kali Cannabis Therapies subsidiary were ongoing research and development will be conducted for the purposes of producing cannabis treatments for specific conditions.
Kali-Extracts is today releasing summary results of one of many preclinical research studies in order to present an example of the underlying value of Kali-Extracts overall cannabis biotechnology intellectual properties. An upcoming independent analyst research report on Kali-Extracts from Goldman Small Cap Research is expected to include a more comprehensive analysis of Kali-Extracts overall body of cannabis biotechnologies.
NCM Biotech (acquired by Kali-Extracts) in collaboration with Beech Tree Labs, Inc. (BTL) of Providence, Rhode Island, conducted a series of in vitro genomic experiments to evaluate the potential of cannabis extracts derived from KALY’s patented extraction process in the treatment of respiratory diseases. The experiments were designed to evaluate pure cannabis extracts and cannabis extracts in combination with other therapies in the treatment of chronic obstructive pulmonary disease (COPD) and Asthma. There are a significant number of genes associated with COPD and Asthma. The experiments evaluated the ability of various formulations to change Asthma or COPD associated gene expressions in human small airway epithelial cells. A cannabis extract alone demonstrated remarkable activity in gene arrays by up- or down-regulating individual genes by as much as 200-fold. Genes appearing especially sensitive to the introduction of cannabis extract were associated with inflammation, healing and cancer inhibition. Results from this series of experiments provided a baseline for comparison with data from subsequent studies.
In the conduct of the study, human small airway epithelial cells (HSAEpC) were purchased from PromoCell (C-12642, Heidelberg Germany). The cells were cultured in small airway epithelial cell growth medium (C-21070) supplemented with growth medium supplement mix (C-39175). When the cells reached sufficient numbers to set up the experiment, airway epithelial cells were seeded in 6 well plates at a density of 200,000 cells per well. Cells were allowed to adhere to the bottom of the plates overnight. The following day, cells were exposed to the treatments for 24 hours. At the end of 24 hours, cells were rinsed with 1X PBS and harvested with TRIzol (Life Technologies, Carlsbad CA). Extractions for mRNA were performed at BTL facilities, quality and quantity of the mRNAs were checked using nanodrop at Brown University Genomics Core Facility. Each treatment had four replicates.
Based on the promising results of the respiratory treatment preclinical research study, NCM Biotech initiated a physiological study which has since been concluded with the research report to be forthcoming soon.
According to the World Health Organization, 65 million people have moderate to severe COPD with three million deaths annually. The treatment of COPD is currently estimated to be $5 billion in the United States and $11 billion worldwide. Some observers estimate that COPD is grossly under-diagnosed and that the market would grow significantly if improved therapeutic agents with less severe side effects were introduced as side effects prevent many COPD patients from using currently approved drugs.
“I believe the underlying value of Kali-Extracts cannabis biotechnology properties are as of yet unrecognized by the market,” said Frederick Ferri, CEO of Kali-Extracts. “Doctors involved in research with our extracts have given me feedback that our extracts are superior to those of GW Pharmaceuticals [GW Pharmaceuticals, plc (NASDAQ: GWPH)]. As just one example of what our cannabis biotechnology can lead to, I believe our developing COPD therapies in combination with the potential for us to harness the patented RapidMist buccal cavity drug administration technology of Generex [Generex Biotechnology, Corp. (OTCQB: GNBT)] through our US Cannabis Health partnership, would put Kali-Extracts in front of any cannabis biotechnology company on the market. For that matter, I think Generex applying its patented RapidMist buccal cavity administration technology would bode well for Generex as well. I also happen to think that the combination of our COPD technology with the RapidMist technology of Generex would illustrate that GW Pharmaceuticals buccal drug administration is likely an infringement on Generex’s RapidMist patent. In summary, the market has a lot yet to learn about Kali-extracts cannabis biotechnology. I hope the COPD example herein begins to give a glimpse of that yet to be relized value. Finally, I think the developing partnership between KALY and its other US Cannabis Health partners with Generex can put KALY, its other US Cannabis Health partners and Generex on top of their respective markets.”
KALY has entered into a joint venture agreement named US Cannabis Health with Puration, Inc. (USOTC: PURA), and Nouveau Pharmaceuticals, Inc. (USOTC: NOUV) to combine their respective resources for the specific purpose of developing partnerships with major pharmaceutical companies to produce medical cannabis therapies.
To learn more about Kali-Extracts, Inc., visit www.kali-extracts.com
wow from calling my statement stupid the other day to saying it is real. we are up 80% so far today. come on pjet get us current. and give us an update. something is cooking.
just out
PURA and KALY Listed Among Top Companies To Benefit From 2018 Farm Bill And Hemp Legalization
Print
As Hemp Bill is on Brink of Legalization Cannabis Stocks Poised for Green Rush
Palm Beach, FL -- December 19, 2018 -- InvestorsHub NewsWire -- FinancialNewsMedia.com News Commentary
The cannabis market is aiming to end 2018 on a high note after a year full of momentum from moments like Canada'sfull-legalization, the Farm Bill in the United States and overall growth on the consumer side as more and more people have access to both Cannabis and CBD-based products. In America, the Hemp Bill is a massive step toward the end of prohibition of cannabis as a whole, on track to being legal across the U.S. which is expected to generate massive growth opportunities in the cannabis industry. Tucked inside the Farm Bill are several provisions that clear the way to making industrial hemp a regular agricultural crop, fueling experts belief the hemp market itself could generate annual revenues north of $20 billion by 2020. From a business opportunity idea, with industrial hemp expected to be treated like any other agricultural product many anticipate several key roadblocks that have slowed growth to be removed, namely free access to the federal U.S. banking system, unrestricted interstate commerce as well as access to federally backed farm support programs. Active Companies from around the market with current developments this week include: Sugarmade, Inc. (OTC: SGMD), Medical Marijuana Inc. (OTC: MJNA), Hemp Inc. (OTC: HEMP), Marijuana Company of America Inc. (OTC: MCOA), Kali Inc. (OTC: KALY).
Sugarmade, Inc. (OTCPK:SGMD) BREAKING NEWS: Sugarmade believes the passage of the U.S. Farm Bill, which includes specific hemp cultivation and legalization provisions creates additional revenue and investment opportunities for the Company as farmers across the country announce plans to begin or expand the cultivation of hemp. Sugarmade provides multiple products for the cultivators and processors and is in process of bringing additional products into this marketplace.
The markets for industrial hemp, CBD oils and other hemp products are widely expected to explode upon implementation of the hemp provisions in the Farm Bill. Several analysts are now forecasting that the market for hemp and CBD will exceed even the size of the booming THC marijuana market.
"Our vast experience in the supply of cultivation, harvesting and processing products places Sugarmade in a strong position to increase its revenue and profit outlooks as dozens of new operations prepare to come online," commented Jimmy Chan, CEO of Sugarmade. "Many of our current products apply directly to the industrial hemp market, which is now opening up. Additionally, we will be marketing other products directly to this emerging market, particularly relating to post-harvest processing. We see this an important market in which we plan to be involved."
In addition to sales of hemp market related supplies, Sugarmade also holds an option to invest up to $1 million in Kentucky hemp operation, Hempistry, Inc., which recently successfully harvested its first 100 acre test crop. Plans are currently underway to significantly increase cultivation operations for the 2019 planting season.
Mr. Chan continued, "We are especially pleased with the specific provisions in the Farm Bill that include legalization of cannabidiol products. We think the inclusion of CBD into foods, beverages and other consumer products will continue to grow, creating additional markets for participants in the North American hemp industrial complex. We believe Sugarmade is very well prepared to capitalize on these booming markets." Read this and more news for Sugarmade at: http://www.financialnewsmedia.com/news-sgmd
In other industry developments and happenings in the market this week include:
Hemp Inc. (OTCPK:HEMP) recently commented on the 2018 Farm Bill. The measure easily passed the lower chamber of the House by a 369-47 vote. The legislation, which passed the Senate in an 87-13 vote on Tuesday, allows for farm subsidies and has language that federally legalizes industrial hemp production. "This is a historic decision for our nation," said Hemp, Inc. CEO Bruce Perlowin. "Our company had the foresight to begin research granted in the 2014 Farm Bill, and have been awaiting progress on the 2018 Farm Bill for quite some time. Since our company has been operational in multiple states over the years, providing the necessary infrastructure for farmers to maximize their output, we know that this legislation will benefit local economies tremendously." According to Perlowin, Hemp, Inc. has spent $25 million on building its industrial hemp infrastructure ($3 million over the course of 5 years building out the infrastructure in Arizona, $20 million building out the infrastructure in North Carolina, and $2 million in Oregon building out its infrastructure which only took 90 days). In Oregon, Hemp, Inc. employed over 200 locals at the height of this year's harvest.
Medical Marijuana Inc. (OTCPK:MJNA) recently announced that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has been named one of the "10 Key Players to Watch in the Cannabis Industry" by Technology Headlines Magazine. "We are thrilled to be named as one of The Technology Headlines' 10 Key Players to Watch in the Cannabis Industry," said Kannaway® CEO Blake Schroeder. "This kind of media coverage helps us showcase our continuing accomplishments and explain how much we care about expanding the CBD industry - continuing our mission of helping others around the world."
Marijuana Company of America Inc. (OTCQB:MCOA) last week announced the launch of a new corporate hempSMART™ website and marketing platform for its associates. By implementing this new associate platform, hempSMART's customers now have the ability to subscribe monthly to our products creating a pathway to generate an annuity stream of monthly reoccurring revenue with minimal follow up. Since Q3, the Company has already seen an increase in associate signups with the new marketing platform and it is expected that Q4 of 2018 will feature the highest generated revenue of the Company's history. The new hempSMART platform is focused on incentivizing our current and future associates to take full advantage of our newly structured compensation plan. MCOA anticipates an increase in sales and a continuous influx of associate signups towards year end.
Kali Inc. (OTCPK:KALY) and Puration, Inc. (OTCPK:PURA) recently announced a THC extraction partnership. The two companies will combine efforts and resources in the extraction of THC for respective products to be produced by the two companies. PURA requires THC extract for its new THCSavor Beverage and KALY plans to produce THC extract for vapes. KALY owns a patented cannabis extraction process which PURA has licensed for specific purposes to include PURA's primary business, the production of cannabis infused beverages. Together, PURA and KALY plan to contract licensed extraction facilities in Colorado and California to produce THC under KALY's patented process and supervision. PURA and KALY, through their partnership, expect to optimize economies of scale in the production of high-quality THC extract.
gap up just increased.
cant wait to see the research report to come out.
pjet number 2 on break out board
Kali-Extracts, Inc. Announces Cannabis Biotech Inventor Frederick Ferri as New CEO to Lead Company Into $28 Billion Medical Cannabis Market
PR Newswire
DALLAS, December 19, 2018
DALLAS, December 19, 2018 /PRNewswire/ --
Kali, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today announced Frederick Ferri as the company's new CEO. Mr. Ferri is the inventor of a patented cannabis extraction process. On November 15th, 2018, KALY acquired Mr. Ferri's company NCM Biotech to include the patented cannabis extraction process he invented. The acquisition includes the extensive preclinical trial research conducted with cannabis extracts from the patented cannabis extraction process. The NCM Biotech Medical Advisory Team includes John N. Gaitanis, MD., Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children; Lloyd R. Saberski, M.D., Associate Professor of Anesthesiology and Chronic Pain Management, Yale University, and John McMichael, Ph.D., President & CEO Beech Tree Labs.
"My first act as the new CEO of Kali-Extracts is to announce the new Kali Cannabis Therapies subsidiary," said Mr. Ferri. "I am enthusiastic about the nutritional and wellness products such as Hemp4mula and EVERx that are already generating revenue for Kali-Extracts either through internal product sales or through the licensing of our technology. The extraordinary and yet unrealized value of Kali-Extracts is in the cannabis biotechnology intellectual properties that came with the NCM Biotech acquisition. Kali-extracts now has years of research and studies surrounding a multitude of applications of our proprietary cannabis extracts. In a separate release later today, the company will publish a formal announcement of the Kali Cannabis Therapies subsidiary to include specific information on preclinical research studies on one particular application of our proprietary cannabis extracts."
Charles Yawn, the Chairman of Kali-Extracts and outgoing CEO said, "Mr. Ferri is a brilliant inventor and pioneer in the exploding field of cannabis extracts. Mr. Ferri invented his patented cannabis extraction process for the very purpose of producing cannabis biotechnology alternatives to chemical pharmaceuticals. Kali-Extracts is privileged to have access to arguably the highest quality cannabis extracts in the market for its over-the-counter wellness and nutritional products. The revenue from the over-the-counter sales will set Kali-Extracts apart from its cannabis biotech competitors. Not only do we believe that Kali-Extracts cannabis extracts are superior to those of our biotech competition, but we have a business model that generates revenue now, while most of our competitors have years of research ahead of them to be funded soley by investment dollars before any revenue might be generated through the sale of cannabis pharmaceutical therapies."
news out and more to come today.
Kali-Extracts, Inc. Announces Cannabis Biotech Inventor Frederick Ferri as New CEO to Lead Company Into $28 Billion Medical Cannabis Market
PR Newswire
DALLAS, December 19, 2018
DALLAS, December 19, 2018 /PRNewswire/ --
Kali, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today announced Frederick Ferri as the company's new CEO. Mr. Ferri is the inventor of a patented cannabis extraction process. On November 15th, 2018, KALY acquired Mr. Ferri's company NCM Biotech to include the patented cannabis extraction process he invented. The acquisition includes the extensive preclinical trial research conducted with cannabis extracts from the patented cannabis extraction process. The NCM Biotech Medical Advisory Team includes John N. Gaitanis, MD., Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children; Lloyd R. Saberski, M.D., Associate Professor of Anesthesiology and Chronic Pain Management, Yale University, and John McMichael, Ph.D., President & CEO Beech Tree Labs.
"My first act as the new CEO of Kali-Extracts is to announce the new Kali Cannabis Therapies subsidiary," said Mr. Ferri. "I am enthusiastic about the nutritional and wellness products such as Hemp4mula and EVERx that are already generating revenue for Kali-Extracts either through internal product sales or through the licensing of our technology. The extraordinary and yet unrealized value of Kali-Extracts is in the cannabis biotechnology intellectual properties that came with the NCM Biotech acquisition. Kali-extracts now has years of research and studies surrounding a multitude of applications of our proprietary cannabis extracts. In a separate release later today, the company will publish a formal announcement of the Kali Cannabis Therapies subsidiary to include specific information on preclinical research studies on one particular application of our proprietary cannabis extracts."
Charles Yawn, the Chairman of Kali-Extracts and outgoing CEO said, "Mr. Ferri is a brilliant inventor and pioneer in the exploding field of cannabis extracts. Mr. Ferri invented his patented cannabis extraction process for the very purpose of producing cannabis biotechnology alternatives to chemical pharmaceuticals. Kali-Extracts is privileged to have access to arguably the highest quality cannabis extracts in the market for its over-the-counter wellness and nutritional products. The revenue from the over-the-counter sales will set Kali-Extracts apart from its cannabis biotech competitors. Not only do we believe that Kali-Extracts cannabis extracts are superior to those of our biotech competition, but we have a business model that generates revenue now, while most of our competitors have years of research ahead of them to be funded soley by investment dollars before any revenue might be generated through the sale of cannabis pharmaceutical therapies."
had time to make a small post about going to the children's hospital but did not say a word about the update he said we would get today. what a jerk.
I sure hope they get their filings updated before any real run here. would hate to see them get hit with a ce like kaly did.
he loves to tweet so much he should at least tweet on why no update like he said there would be today.
cant wait for the goldman report. I believe it will be money well spent to help investors put the big picture together. this is going to be great.
where is the update we where going to get today.
my long shot guess on news tomorrow. it will be between evsv and kaly. working out deals with growers of hemp. kaly will have the mobile extraction units and evsv with a type of pest control that the growers can use. evsv and kaly will work together with the growers of hemp. just my gress. and that is partly do to the fact that evsv made sure to put in their tweet that he would be in florida when the update is released. I believe that is where kaly is.
I believe tomorrow will be better then today. I think we will see some more news tomorrow and then by the end of the week we are supposed to see the coverage on kaly. this is looking great. I haven't been wrong yet on what I have called for kally.
order for 100 pallets of happy water. happy water is going to make us all happy.
my bet is we will see some type of damage control or good news tomorrow. then Tuesday we will see something between kaly and evsv. I believe kaly was head quartered in Florida and are moving to tex. evsv made sure they tweeted updated coming Tuesday but he will not be there. that he will be in Florida. why would he have to say he would not be around when the update comes out that he will be in Florida.
cant believe people are still going back and forth on the ce. it is simple. if you go to the otc and read the response from kaly to the otc any one can see that it was due to not being up to date. with not being up to date and the big volume and rise of the pps the otc put up the ce to protect the investors. in response to the otc kaly said they where ready to file every thing they needed to. and they did what they said. they got all the filings into the otc. the only thing we do not know is if they went back far enough for the otc and do they still need to file an attorney letter. but we do know for sure it was do to the lack of filings that had the otc put up the ce to protect the investors. if more filings are needed I would bet we will see some more Monday. my guess that is also why evsv is waiting till Tuesday for an update. things are coming together. and we should all be able to see the big picture soon. so relax.
lets hope things start to come together with these companies next week. kaly filings and hope to come current and evsv tweeted they will have an update Tuesday. just maybe the big picture will start to come together.
lets hope things start to come together with these companies next week. kaly filings and hope to come current and evsv tweeted they will have an update Tuesday. just maybe the big picture will start to come together.
lets hope things start to come together with these companies next week. kaly filings and hope to come current and evsv tweeted they will have an update Tuesday. just maybe the big picture will start to come together.
the skull is old news now. financials being filed today like they said. the skull will go and pink current will come.
more filings submitted.
get every thing filed and we could start the week current pink.
some of the filings starting to come in like they said.
wouldn't it be great to see pura and kaly come out with some real good news this afternoon. watch it start to rebound and have those that sold regret it. in the mean time I keep checking to see some of the filings start to come in. lets go kaly get them filed you said they are ready. lets get this done I want to see us go current. and hope they learned a lessen with this. get all companies involved current before the run starts.
in the release today it says they plan to start updating filings today. would hope to see some of it being done while the market is open to show investors it is being done.
I like the part where they say they plan to start the filing of updates to the otc today. would be nice to see them go current next week. glta.
I would not look for new highs today unless kaly jumps in with something to say. volume and postings are both drying up. I would have to believe most investors are waiting for kaly to address things. and if they don't we could go lower.
just disappointed that the company has not jumped in to say anything. hard to believe any good company would not address a bad situation. they should have something to say about this. want to keep the confidence of the investor then address the situation and show concern for the situation and the investors.
just hard to believe that the company has yet to put anything out to address the situation. thought for sure they would have addressed it first thing this morning before pre market.
so hard to believe the extent some will go to try and get others to buy or sell. first you have the idiots that say skull and cross bones. I am shaking I am up over a 1000% so far. am I going to loose it tomorrow. what crap. then on the other hand you have someone pull up their trading screen and type in .25 is any one that stupid they cant tell it is the trading screen and you can type in what ever you want. these are people that should be banned from posting on the boards. we traded over 200,000,000 shares today. I would bet anything that only a small fraction of that is from people that post here. these people need to go home and suck on moms tit and maybe they will feel better because the carp they post here means nothing.
yes look at the bright side. we got another tweet tonight. what good shape the farm bill puts evsv in. but nothing on any details on what it is doing for us. maybe trying for the king of tweets.
maybe we should all buy some more shares. you never know. we may get another useless tweet about how great they are doing with no info.
sure would be great to see a research report on this like they did with pura.
pura and kaly put out news. kaly taking off. poor evsw with nothing but stupid tweets. almost like they are being left out in the cold. and to think they tweeted they have done more in two weeks then others have done in a year and how great it went in Carolina. you would think they would have some good news to put out unless it was all bull crap. jmo
ok broke the penny. lets see if we start trading in bigger increments. time to catch up with pura.
news out
CHATSWORTH, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Trimax Corporation, Inc. (OTC PINK: TMXN) (the "Company") and its wholly owned subsidiary Saavy Naturals Inc., is pleased to announce they have surpassed 200 Walmart locations for their luxurious handcrafted soaps which is a part of their Saavy Naturals Everyday brand.
As previously reported, Walmart originally approved the roll-out of Saavy Naturals Everyday's beautiful free-standing custom-made pallet displays, which hold 1,152 individual soaps in 12 captivating scents, to 50 Walmart locations in Texas. Since October, the Company has received purchase orders for over 200 Walmart locations and now distributes their handcrafted soaps to the states of Indiana, Texas, Tennessee, New Hampshire, Arizona, Florida, Michigan, Virginia, Oregon, Colorado, New York, Wisconsin, Missouri, Pennsylvania, California, Illinois, Montana, Louisiana, Delaware, Alabama, North Carolina, Kentucky and Mississippi.
The Company eagerly anticipates continued consistent weekly orders from Walmart as they continue to expand their locations in order for the company to reach their goal of distributing to over 1,000 Walmart locations nationwide.
Hugo Saavedra, CEO of Trimax Corporation and Saavy Naturals Inc., stated, "We are extremely pleased to announce that our handcrafted soaps have now expanded from 50 stores in one state to over 200 locations in 23 states over the last two months. We are confident that we will hit our goal of distributing to 1,000 locations throughout all 50 states." He also stated, "We continue to experience consistent sales of our Savvy Naturals Everyday bath bombs to Walmart throughout the U.S. as well."
Hugo and Debra Saavedra, Saavy Naturals Inc.'s, CEO and President, gained instant popularity for their all-natural body care product line after being spotlighted and appearing on ABC's hit show Shark Tank. The Sharks took an instant liking to Hugo and Debra, their love story, their previous success in the body care industry, and the superior quality of their all-natural product. Hugo and Debra have since increased the company's product line exposure with several highlighted television features on The Home Shopping Network and are currently working on additional television marketing opportunities.
news just came out.
Kali-Extracts Introduces Hemp4mula CBD Infused Candy and Vapes Logo Design
PR Newswire
DALLAS, Dec. 12, 2018
DALLAS, Dec. 12, 2018 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") introduced today the logo design for its Hemp4mula CBD infused candies and vapes. Last week, Kali-Extracts announced launching its own line of hemp-derived CBD infused candies and vapes under the brand name Hemp4mula. The company also announced initiating production on Hemp4mula gum with a wholesale order anticipated immediately after the completion of the hemp-derived CBD infused gum production. Kali-Extracts expects to produce hemp-derived CBD infused mints and gummies shortly after completing production of the gum. Hemp4mula vapes are anticipated to be in production early next year.
KALY recently acquired a biotech company with a patented cannabis extraction process. Accordingly, KALY updated its overall business plan (a presentation on the company's updated business plan is available on KALY's website). Hemp4mula is part of the updated business plan which management is rapidly executing. The company announced a $300,000 hemp-derived CBD extraction contract with Puration, Inc. (USOTC: PURA) earlier this week. The CBD Kali-extracts will produce is to support PURA's contract to produce a private labeled CBD infused Water for Generex Biotechnology, (OTCQB: GNBT).